Trial Profile
Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs FPF 1070 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms E-COMPASS
- 10 May 2016 Status changed from recruiting to completed.
- 05 Dec 2013 New trial record